These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 30599112)
1. PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs? Aruleba RT; Adekiya TA; Oyinloye BE; Masamba P; Mbatha LS; Pretorius A; Kappo AP Infect Disord Drug Targets; 2019; 19(4):337-349. PubMed ID: 30599112 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon. Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803 [TBL] [Abstract][Full Text] [Related]
4. The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment. Koukounari A; Donnelly CA; Sacko M; Keita AD; Landouré A; Dembelé R; Bosqué-Oliva E; Gabrielli AF; Gouvras A; Traoré M; Fenwick A; Webster JP BMC Infect Dis; 2010 Jul; 10():227. PubMed ID: 20670408 [TBL] [Abstract][Full Text] [Related]
5. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns. Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016 [TBL] [Abstract][Full Text] [Related]
6. The promise of antimicrobial peptides for treatment of human schistosomiasis. Oyinloye B; Adenowo F; Gxaba N; Kappo A Curr Drug Targets; 2014; 15(9):852-9. PubMed ID: 25101908 [TBL] [Abstract][Full Text] [Related]
7. The Journey to Discovering a Flatworm Target of Praziquantel: A Long TRP. Park SK; Marchant JS Trends Parasitol; 2020 Feb; 36(2):182-194. PubMed ID: 31787521 [TBL] [Abstract][Full Text] [Related]
9. Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel. Chienwichai P; Tipthara P; Tarning J; Limpanont Y; Chusongsang P; Chusongsang Y; Adisakwattana P; Reamtong O PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009706. PubMed ID: 34473691 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy. Fukushige M; Chase-Topping M; Woolhouse MEJ; Mutapi F PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009189. PubMed ID: 33730095 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Harder A Parasitol Res; 2002 May; 88(5):395-7. PubMed ID: 12049454 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs. Levecke B; Vlaminck J; Andriamaro L; Ame S; Belizario V; Degarege A; Engels D; Erko B; Garba AD; Kaatano GM; Mekonnen Z; Montresor A; Olliaro P; Pieri OS; Sacko M; Sam-Wobo SO; Tchuem Tchuenté LA; Webster JP; Vercruysse J Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():183-187. PubMed ID: 33125936 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger. Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014 [TBL] [Abstract][Full Text] [Related]
14. In vivo efficiency of praziquantel treatment of single-sex Schistosoma japonicum aged three months old in mice. Wang N; Peng HQ; Gao CZ; Cheng YH; Sun MT; Qu GL; Webster JP; Lu DB Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():129-134. PubMed ID: 36403362 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneities in anti-schistosome humoral responses following chemotherapy. Mutapi F Trends Parasitol; 2001 Nov; 17(11):518-24. PubMed ID: 11872396 [TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents. Liu LX; Li-Li J; Qiong C; Xiao-Lin F Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801 [TBL] [Abstract][Full Text] [Related]
17. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial. Hoekstra PT; Casacuberta Partal M; Amoah AS; van Lieshout L; Corstjens PLAM; Tsonaka S; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ BMC Infect Dis; 2018 Dec; 18(1):662. PubMed ID: 30547750 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Wang W; Wang L; Liang YS Parasitol Res; 2012 Nov; 111(5):1871-7. PubMed ID: 23052781 [TBL] [Abstract][Full Text] [Related]
19. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Doenhoff MJ; Cioli D; Utzinger J Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535 [TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum. Bustinduy AL; Kolamunnage-Dona R; Mirochnick MH; Capparelli EV; Tallo V; Acosta LP; Olveda RM; Friedman JF; Hope WW Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]